Company Search:
Advanced Search
Sponsored Links
Apex Biotechnology Corporation Company Snapshot
Apex Biotechnology Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apex Biotechnology with three other companies in this sector in Taiwan: OK Biotech Co Ltd (2015 sales of 856.55 million Taiwanese Dollars [US$27.22 million] of which 100% was Ok Biotech Co Ltd), Taidoc Technology Corporation (2.64 billion Taiwanese Dollars [US$83.80 million] of which 65% was Electro Medical Apparatus Manufacturing), and Bionime Corporation (1.61 billion Taiwanese Dollars [US$51.16 million] of which 100% was Manufacturing Medical Equipment & Medica).

Sales Analysis. During the year ended December of 2015, sales at Apex Biotechnology were 1.85 billion Taiwanese Dollars (US$58.71 million). This is an increase of 3.3% versus 2014, when the company's sales were 1.79 billion Taiwanese Dollars. The sales level in 2015 was fairly close to the level five years ago: in 2010, Apex Biotechnology had sales of 1.75 billion Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Apex Biotechnology Corporation
  Stock Performance Chart for Apex Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 41.65
(Figures in Taiwanese Dollars)
1 Week -0.6%   13 Weeks -4.9%  
4 Weeks -17.4%   52 Weeks -2.7%  
Apex Biotechnology Corporation Key Data:
  Ticker: 1733 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 1,847,454,000
(Year Ending Jan 2016).
Employees: 641
  Currency: Taiwanese Dollars Market Cap: 4,152,671,600
  Fiscal Yr Ends: December Shares Outstanding: 99,704,000
  Share Type: Gu Closely Held Shares: 13,267,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.